Cardiac Rhythm Management Patent Landscape 2026
Cardiac rhythm management is a highly concentrated, maturing field dominated by established medical-device incumbents, with Medtronic holding the largest single position among the top-ranked filers. Annual filing volume peaked in 2017 and has trended downward since, signaling a field past its period of peak invention intensity.
Medtronic leads a tightly held field with a clear tier gap below it
Medtronic is the dominant filer, ranking first among the top hundred applicants. Cardiac Pacemakers, West Affum, Pacesetter, and Cameron Health round out the top five, together accounting for 48% of combined patent records among the hundred largest filers.
The concentration is pronounced: the five leading applicants collectively hold nearly half the weight among top-100 filers, and the drop from the top tier to mid-tier names is steep. Applicants outside the top five hold substantially smaller individual positions.
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 1 | Medtronic Inc | 913 | |
| 2 | Cardiac Pacemakers Inc | 641 | |
| 3 | West Affum Holdings DAC | 424 | |
| 4 | Pacesetter Inc | 381 | |
| 5 | Cameron Health Inc | 320 | |
| 6 | Koninklijke Philips NV | 307 | |
| 7 | ZOLL Medical Corporation | 265 | |
| 8 | Physio-Control Corp | 261 | |
| 9 | BIOTRONIK SE & CO KG | 173 | |
| 10 | Intermedics Inc | 154 |
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 11 | ELA Medical SA | 121 | |
| 12 | Stryker Corporation | 100 | |
| 13 | Avive Solutions Inc | 86 | |
| 14 | Angeion Corporation | 80 | |
| 15 | CardioThrive Inc | 66 | |
| 16 | Cardiac Science Corporation | 65 | |
| 17 | Everest Acquisition Entity LLC | 64 | |
| 18 | St Jude Medical AB | 62 | |
| 19 | West Affum Holdings Corp | 57 | |
| 20 | Element Science Inc | 52 |
The leaders’ scale implies deep freedom-to-operate barriers for new entrants attempting core electrotherapy filings. Challengers such as Biotronik, ZOLL Medical, and Koninklijke Philips occupy distinct but smaller positions and represent the field’s competitive second tier.
Filing counts for 2024–2026 are likely under-represented due to standard patent-publication lag of 18–24 months and should not be read as evidence of accelerating decline. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Volume has retreated from a 2017 peak; electrotherapy dominates the technology mix
The filing trend chart shows how annual activity has evolved since 2017, while the technology-composition chart reveals where innovation effort has concentrated across IPC classes.
Annual filing trend
Annual filing activity peaked at 314 records in 2017 and has fallen in most subsequent years. The field is in a declining phase on this multi-year basis. Data for 2024–2026 is subject to publication lag and will rise as pending applications publish.
↗ Hover for values · click a bar to ask EurekaTechnology composition
A61N (electrotherapy and radiation therapy) overwhelmingly dominates the technology mix, reflecting the core pacing and defibrillation focus of the field. A61B (diagnosis and surgery) is a distant second. Smaller branches — including G16H (healthcare informatics), G06F (digital data processing), H01M (batteries), and H04W (wireless networks) — each represent 2% or less of records, indicating that adjacent enabling technologies remain lightly covered relative to the core.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Cardiac pacemaker system for usage in combination …
A cardiac pacing system comprising one or more leadless cardiac pacemakers configured for implantation in electrical contact with a cardiac chamber and configured to perform cardiac pacing functions in combination with a co-implanted implantable cardioverter-defibrillator (ICD). The leadless cardiac pacemaker comprises at least two leadless electrodes… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Apparatus for monitoring electrical physiologic si… | 1,498 |
| 2 | System and method for detecting performance compon… | 1,200 |
| 3 | Interactive programming and diagnostic system for … | 1,095 |
| 4 | System for producing prioritized alarm messages in… | 958 |
| 5 | Method and apparatus for implementing activity sen… | 885 |
| 6 | Implantable capacitive absolute pressure and tempe… | 846 |
| 7 | Rechargeable biomedical battery powered devices wi… | 789 |
| 8 | Defibrillation system having segmented electrodes | 780 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the patent structure means for R&D investment decisions
Four structural observations — maturity stage, concentration, collaboration patterns, and geographic reach — shape the risk and opportunity calculus for any team entering or expanding in this space.
Field is in decline from a 2017 peak
The lifecycle evidence classifies cardiac rhythm management as Decline, with annual filings easing back from the 2017 peak of 314 records. The multi-year window reflects a field where core electrotherapy inventions are well-staked and incremental filings are diminishing. New entrants face a mature IP landscape requiring differentiated positioning — particularly in adjacent enabling technologies — rather than direct competition in the saturated core.
Lifecycle: DeclineTop five control nearly half of large-filer activity
The top five applicants among the hundred largest filers hold a combined 48% share of that group’s patent records, a level that reflects high structural concentration. The gap between Medtronic (913 records) and the fifth-ranked Cameron Health (320 records) is substantial. Mid-tier players like Biotronik (173 records) and ELA Medical (121 records) occupy defensible but narrower niches. For an entrant, this concentration means that broad freedom-to-operate clearance in core pacing and defibrillation is both necessary and costly.
High concentrationIndustry-academia links are narrow and centered on Cardiac Pacemakers
The most active co-filing pair is Cardiac Pacemakers and Duke University, with 18 joint records — the clearest industry-academia link in the dataset. Koninklijke Philips co-filed with the University of Washington (3 records) and Cardiac Pacemakers co-filed with Columbia University (2 records) and the State University of New York Research Foundation (2 records). West Affum and Physio-Control collaborated on 2 records. Overall, the collaboration network is sparse, suggesting that most R&D remains vertically integrated within individual corporate entities.
Sparse collaborationUnited States is the primary protection jurisdiction by a wide margin
The United States leads all jurisdictions by a substantial margin. Europe (EPO) is the second most common filing destination, followed by WIPO (PCT) as a route to international coverage. Australia, Canada, and China represent meaningful secondary markets. Emerging economies such as India, Brazil, and South Korea show very limited coverage, which may reflect both market-size considerations and the maturity of underlying technology. Any strategy targeting global commercialization should assess whether EPO and PCT coverage is sufficient given thin protection in high-growth geographies.
US-centric protectionGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| Cardiac Pacemakers Inc | Duke University | 18 |
| Koninklijke Philips NV | University of Washington | 3 |
| Cardiac Pacemakers Inc | The Trustees of Columbia University in the City of New York | 2 |
| Cardiac Pacemakers Inc | Research Foundation of State University of New York | 2 |
| West Affum Holdings DAC | Physio-Control Corp | 2 |
| Koninklijke Philips NV | PHILIPS GMBH | 2 |
| Medtronic Inc | TAN Co Ltd | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
Medtronic anchors a stable top tier; Biotronik shows the strongest recent momentum
The ranking is dominated by companies with long histories in implantable and external cardiac devices. Recent filing momentum diverges sharply across the top names, with some incumbents contracting while at least one is actively expanding.
Medtronic Inc
Medtronic holds 913 patent records, the largest position among all ranked applicants, with its filings concentrated heavily in A61N 1 (electrotherapy), complemented by A61B 5 (diagnosis and surgery) and H01G 9 (capacitors). Recent filing trend is flat at 0%, indicating a stable rather than growing position — consistent with a mature incumbent maintaining rather than expanding its portfolio footprint.
913 patent recordsBiotronik SE & Co KG
Biotronik holds 173 patent records and shows the strongest recent filing momentum of any named applicant, with a trend of +76% compared to its prior three-year period. Its focus spans A61N 1 (electrotherapy), A61B 5 (diagnosis and surgery), and H01Q 1 (antennas) — the antenna work hinting at wireless telemetry differentiation. For a team assessing competitive dynamics, Biotronik is the incumbent most actively investing at current rates.
173 patent records| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Medtronic Inc | 44 | ▬ 0% |
| Cardiac Pacemakers Inc | 6 | ▼ -65% |
| West Affum Holdings DAC | 30 | ▼ -79% |
| Koninklijke Philips NV | 13 | ▲ new entrant |
| Pacesetter Inc | 20 | ▼ -13% |
| Physio-Control Corp | 5 | ▲ new entrant |
| ZOLL Medical Corporation | 44 | ▲ +16% |
| Biotronik SE & Co KG | 58 | ▲ +76% |
Under-served adjacent branches in informatics, energy storage, and wireless
While A61N electrotherapy commands the dominant share of records, several adjacent IPC branches are sparsely populated relative to the core. These represent areas where coverage is thin and where technical convergence with cardiac rhythm management is plausible — though entry feasibility depends on each team’s existing IP position and technical capabilities.
G16H · Healthcare Informatics
Healthcare informatics accounts for 208 records (approximately 2% of all branch-level records), a low count for a branch directly relevant to remote monitoring, predictive algorithms, and closed-loop cardiac management. As pacemakers and defibrillators increasingly depend on data connectivity and AI-assisted decision support, the informatics layer is under-patented relative to its clinical importance. Teams with strengths in health data platforms or clinical decision systems could find differentiated entry points here that avoid the saturated A61N core.
Search this in Eureka →H01M · Batteries, Cells & Fuel Cells
Battery and energy storage technology (H01M) covers only 94 records, representing approximately 1% of branch-level records in this landscape. Implantable cardiac devices are fundamentally constrained by energy source longevity and form factor. Sparse patenting in this branch suggests that energy storage innovation — particularly solid-state or miniaturized cell chemistries optimized for implantable applications — is not yet well-claimed by cardiac-device incumbents. Organizations with battery technology expertise may find this an adjacent path with a defensible technical rationale.
Search this in Eureka →How leading applicants differ across technology routes
Route coverage across the main technology branches in the current evidence set.
| Player | A61N 1 · Electrotherapy & radiation therapy | A61B 5 · Diagnosis & surgery | A61H 31 · Physical therapy & massage | G16H 40 · Healthcare informatics | G16H 20 · Healthcare informatics |
|---|---|---|---|---|---|
| Medtronic Inc | Strong · 920 | Moderate · 207 | Absent | Absent | Absent |
| Cardiac Pacemakers Inc | Strong · 559 | Emerging · 104 | Absent | Absent | Absent |
| West Affum Holdings DAC | Strong · 334 | Strong · 173 | Absent | Emerging · 20 | Emerging · 13 |
| Koninklijke Philips NV | Strong · 330 | Moderate · 86 | Emerging · 30 | Emerging · 7 | Absent |
| ZOLL Medical Corporation | Strong · 202 | Moderate · 78 | Moderate · 59 | Emerging · 35 | Moderate · 44 |
| Physio-Control Corp | Strong · 242 | Moderate · 49 | Emerging · 15 | Emerging · 34 | Emerging · 38 |
| Cameron Health Inc | Strong · 307 | Emerging · 50 | Absent | Absent | Absent |
Frequently asked questions
The corpus covers 1,682 patent families in scope. Separately, applicant rankings are measured at the patent-record level, which can differ from family counts because a single family may be filed across multiple jurisdictions.
Medtronic Inc is the top-ranked filer with 913 patent records, well ahead of the second-ranked Cardiac Pacemakers Inc at 641 records.
No. The evidence classifies the field in a Decline lifecycle stage. Annual filing volume peaked in 2017 at 314 records and has trended downward in most subsequent years. The most recent years (2024–2026) are subject to publication lag and will partially recover as pending applications publish, but the multi-year direction is down.
Biotronik SE & Co KG shows the strongest momentum at +76% compared to its prior three-year period. ZOLL Medical Corporation is up +16%. Koninklijke Philips NV and Physio-Control Corp are each characterized as new entrants in recent filings. By contrast, Cardiac Pacemakers is down -65% and West Affum down -79% in recent periods.
The United States leads by a wide margin, followed by Europe (EPO), WIPO (PCT), Australia, Canada, China, and Germany. Protection is heavily concentrated in developed markets, with emerging economies such as India, Brazil, and South Korea receiving relatively sparse coverage.
Healthcare informatics (G16H) at approximately 2% of branch-level records and battery and energy storage (H01M) at approximately 1% are the most technically relevant under-served branches identified in the evidence. Wireless communication networks (H04W) and physical therapy integration (A61H) are also sparse relative to the core electrotherapy class.
Ready to map your own cardiac rhythm management landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.